Diverse Enrollment
Diverse enrollment is the measurable participation of underrepresented populations in clinical trials, aligned with disease burden and real-world data.
What is Diverse Enrollment?
Diverse enrollment refers to actual participant inclusion numbers within a study. It measures whether outreach strategies translate into representation.
Achieving diverse enrollment requires planning early, building community trust, and monitoring progress continuously. Late-stage corrections often increase costs and delay timelines.
Acclinate supports diverse enrollment through proactive education and community-driven engagement strategies. This approach ensures people understand their health, are aware of their trial participation options, and can take actions to improve their well-being.
Diverse enrollment connects strategy to measurable outcomes and expands equitable access to research opportunities.
FAQ
What leads to low diverse enrollment?
Common barriers to participation include mistrust, limited access, logistical barriers, and ineffective outreach.
How is diverse enrollment measured?
It is measured by comparing participant demographics to disease prevalence and target populations.
Can diverse enrollment reduce trial delays?
Yes. Early efforts to diversify enrollment helps prevent late-stage recruitment shortfalls that can lead to riskier market rollouts.
%20(1).webp)
.webp)